RecruitingNCT06451887
Early Identification of Malignant Brain Edema in laRge Artery oCclusive Stroke After Endovascular Therapy (EMBRACE Study)
Sponsor
Zhejiang Provincial People's Hospital
Enrollment
1,950 participants
Start Date
Apr 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To design and validate a predictive model for malignant brain edema after endovascular thrombectomy.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with brain edema, endovascular therapy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06451887
Related Trials
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
NCT0597668530 locations
STROKE 120 ACTION Trial
NCT071353101 location
Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
NCT077135372 locations
Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke
NCT074057622 locations
Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery
NCT073476653 locations